Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

66.81
+0.23000.35%
Post-market: 66.950.1400+0.21%19:59 EDT
Volume:12.68M
Turnover:846.68M
Market Cap:136.01B
PE:14.71
High:67.20
Open:66.25
Low:65.91
Close:66.58
52wk High:68.64
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:1.95
T/O Rate:0.62%
Dividend:2.51
Dividend Rate:3.76%
EPS(TTM):4.54
EPS(LYR):3.46
ROE:46.60%
ROA:10.72%
PB:6.09
PE(LYR):19.31

Loading ...

Bristol-Myers Squibb Expands Pipeline With New First-in-Human Trial for BMS-986533

TIPRANKS
·
Jul 25

Bristol-Myers Squibb Advances New Lung Cancer Combo Into Phase 2: What Investors Should Watch

TIPRANKS
·
Jul 25

Earning Preview: Bristol-Myers Squibb this quarter’s revenue is expected to increase by 3.22%, and institutional views are neutral

Earnings Agent
·
Jul 24

Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 24

India's Cipla Posts Another Profit Decline, Names Insider Dinesh Jain CFO

Reuters
·
Jul 23

Analysts Offer Insights on Healthcare Companies: Celldex (CLDX), Bristol-Myers Squibb (BMY) and Peptidream (OtherPPTDF)

TIPRANKS
·
Jul 22

Sector Update: Healthcare

MT Newswires Live
·
Jul 21

Top Midday Stories: Brookfield, CPP Investments to Acquire LXP; Google Working on New Server Chip

MT Newswires Live
·
Jul 20

Alexandria Real Estate Delivers 427,000 RSF Bristol Myers Squibb R&D Hub at Campus Point San Diego Megacampus

Reuters
·
Jul 20

Bristol Myers expands compute infrastructure to deploy NVIDIA DGX SuperPOD

TIPRANKS
·
Jul 20

Bristol Myers Squibb Partners with Nvidia to Build AI Factory Using DGX Vera Rubin Superpod

Reuters
·
Jul 20

Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with Nvidia

THOMSON REUTERS
·
Jul 20

Bristol Myers Buys Nvidia's Latest AI Computing System for Drug Research

Reuters
·
Jul 20

Bristol Myers Squibb: to Expand Its Compute Infrastructure to Deploy Nvidia Dgx Superpod with Dgx Vera Rubin Nvl72 Systems

THOMSON REUTERS
·
Jul 20

Bristol Myers (BMY) Is Up 5.5% After FDA Accepts Mezigdomide NDA In Multiple Myeloma

Simply Wall St.
·
Jul 19

How Firms Hit Their Numbers by Any Means Necessary: Marty Fridson

Reuters
·
Jul 17

Gyre Therapeutics Adds CSO Yue Xiong, Max Kirkby, Claire Weston to Board Effective Aug. 1

Reuters
·
Jul 17

Movement Alert|Bristol-Myers Squibb Rises 3.01% in Regular Trading, Mezigdomide NDA Acceptance by FDA Continues to Boost Sentiment

Market Focus
·
Jul 17

Bristol Myers Squibb call volume above normal and directionally bullish

TIPRANKS
·
Jul 16

Bristol Myers Squibb Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 16